SCHEMBL10693232

SCHEMBL10693232

CCc1ccc2c3c(cccc13)C(=O)OC2=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 6/20 0.58
▸ MEN1 O00255 6/20 0.42
▸ KMT2A Q03164 6/20 0.42
▸ POLB P06746 3/20 0.42
▸ USP2 O75604 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ KEAP1 Q14145 3/20 0.41
▸ NFE2L2 Q16236 3/20 0.41
▸ CYP1B1 Q16678 2/20 0.41
▸ ATM Q13315 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ MAPT P10636 2/20 0.39
▸ PABPC1 P11940 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24757599 0.88 TYMS (0.53) TYMSMEN1KMT2APOLBUSP2
SCHEMBL17133796 0.85 TYMS (0.50) TYMSMEN1KMT2APOLBUSP2
SCHEMBL31365971 0.85 TYMS (0.50) TYMSMEN1KMT2APOLBUSP2
SCHEMBL10490096 0.82 PABPC1 (0.50) MEN1KMT2APOLBUSP2KDM4E
SCHEMBL15119610 0.80 TYMS (0.45) TYMSMEN1KMT2APOLBALDH1A1
SCHEMBL20869689 0.80 MEN1 (0.59) MEN1KMT2APOLBUSP2KDM4E
SCHEMBL10267341 0.80 TYMS (0.70) TYMSMEN1KMT2APOLBUSP2
SCHEMBL6984126 0.77 MAPT (0.62) TYMSMEN1KMT2APOLBUSP2
SCHEMBL11171228 0.76 KMT2A (0.53) TYMSMEN1KMT2APOLBUSP2
SCHEMBL13495361 0.75 PRMT1 (0.48) MEN1KMT2APOLBUSP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4782064-A THROMBOXANE SYNTHETASE INHIBITORS AMERICAN CYANAMID CO. (US) 1988-11-01 — — US disclosed
Send feedback